Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function

Iron deficiency is common in patients with heart failure and associated with a poor cardiac function and higher mortality. How iron deficiency impairs cardiac function on a cellular level in the human setting is unknown. This study aims to determine the direct effects of iron deficiency and iron repletion on human cardiomyocytes.

• Publication year

  2018

• Venue

  European Journal of Heart Failure

• Publication date

  2018-02-27

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ejhf.1154PMID 29484788PMCID 5993224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multi-color electron microscopy by element-guided identification of cells, organelles and molecules

  2017cited by this paper
• Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis

  2017cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• An essential cell-autonomous role for hepcidin in cardiac iron homeostasis

  2016cited by this paper
• Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure

  2016cited by this paper
• Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure.

  2016cited by this paper
• Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.

  2016cited by this paper
• Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study

  2016cited by this paper
• Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes

  2015cited by this paper
• Scanning EM of non-heavy metal stained biosamples: Large-field of view, high contrast and highly efficient immunolabeling.

  2015cited by this paper
• FLIPPER, a combinatorial probe for correlated live imaging and electron microscopy, allows identification and quantitative analysis of various cells and organelles

  2015cited by this paper
• Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.

  2015cited by this paper
• Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart.

  2015cited by this paper
• Large-Scale Electron Microscopy Maps of Patient Skin and Mucosa Provide Insight into Pathogenesis of Blistering Diseases.

  2015cited by this paper
• Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†

  2014cited by this paper
• Iron i.v. in heart failure: ready for implementation?

  2014cited by this paper
• Chemically defined generation of human cardiomyocytes

  2014cited by this paper
• Heme levels are increased in human failing hearts.

  2013cited by this paper
• Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

  2013cited by this paper
• Erratum to “Site-Specific Antioxidative Therapy for Prevention of Atherosclerosis and Cardiovascular Disease”

  2013cited by this paper
• Phytoagents for Cancer Management: Regulation of Nucleic Acid Oxidation, ROS, and Related Mechanisms

  2013cited by this paper
• Complementary RNA and protein profiling identifies iron as a key regulator of mitochondrial biogenesis.

  2013cited by this paper
• Mitochondrial Dysfunction Induces Formation of Lipid Droplets as a Generalized Response to Stress

  2013cited by this paper
• Iron deficiency in chronic heart failure: an international pooled analysis.

  2013cited by this paper
• Iron depletion increases manganese uptake and potentiates apoptosis through ER stress.

  2013cited by this paper
• Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions

  2012cited by this paper
• The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

  2012cited by this paper
• Development of Polydimethylsiloxane Substrates with Tunable Elastic Modulus to Study Cell Mechanobiology in Muscle and Nerve

  2012cited by this paper
• Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

  2012cited by this paper
• Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches

  2011cited by this paper
• Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

  2011cited by this paper
• Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.

  2011cited by this paper
• Biochemical diagnosis of mitochondrial disorders

  2010cited by this paper
• Iron deficiency: an ominous sign in patients with systolic chronic heart failure.

  2010cited by this paper
• Ferric carboxymaltose in patients with heart failure and iron deficiency.

  2009cited by this paper
• Synthetic and natural iron chelators: therapeutic potential and clinical use.

  2009cited by this paper
• Cellular Uptake and Release of Two Contrasting Iron Chelators

  1999cited by this paper
• Regulation of Iron Regulatory Protein 1 during Hypoxia and Hypoxia/Reoxygenation*

  1998cited by this paper
• Hypoxia Alters Iron Homeostasis and Induces Ferritin Synthesis in Oligodendrocytes

  1995cited by this paper
• Hypoxia Specifically and Reversibly Induces the Synthesis of Ferritin in Oligodendrocytes and Human Oligodendrogliomas

  1994cited by this paper
• Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion.

  1982cited by this paper
• Morphological abnormalities in lymphocyte mitochondria associated with iron-deficiency anaemia

  1974cited by this paper
• Iron Excretion in Thalassaemia Major After Administration of Chelating Agents

  1962cited by this paper
• Iron Excretion in Thalassaemia Major After Administration of Chelating Agents

  1962cited by this paper

• KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).

  2026cites this paper
• Reexamining the Role of Amyloid β Clearance from the Brain: Exporting Labile Iron from the Interstitial Fluid Performs a Protective Function

  2026cites this paper
• The Potential Role of Iron Homeostasis and Ferroptosis in Exercise Nutrition and Health

  2026cites this paper
• Iron deficiency aggravates hepatic inflammation in suckling piglets via endoplasmic reticulum stress-driven NF-κB pathway activation

  2026cites this paper
• Iron Deficiency as a Modifiable Risk Factor in Heart Failure: Evidence and Recommendations

  2025cites this paper
• Machine learning-driven prediction model for cuproptosis-related genes in spinal cord injury: construction and experimental validation

  2025cites this paper
• Iron Deficiency in Cardiovascular Disease　- Diagnosis, Clinical Implications, and Future Directions.

  2025cites this paper
• Iron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions

  2025cites this paper
• Preserved Hemoglobin, Impaired Performance: Rethinking Iron in Fontan Circulation.

  2025cites this paper
• Comparative phenotyping of C57BL/6J substrains reveals distinctive patterns of cardiac aging

  2025cites this paper
• The Role of Myocardial Fibrosis and Bioenergetic Dysfunction in Heart Failure Prognosis: A Study Protocol

  2025cites this paper
• Hepcidin, Incident Heart Failure and Cardiac Dysfunction in Older Adults: the ARIC Study.

  2025cites this paper
• Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial

  2025cites this paper
• Iron Deficiency in Acute Coronary Syndromes - Clinical Correlates and Outcomes.

  2025cites this paper
• Targeting macro- and micro-nutrient regulation of H2S signaling for the aging brain

  2025cites this paper
• Ferroptosis-related stress during aging and its relevance to disease.

  2025cites this paper
• Management of patients with iron deficiency anemia in the context of primary health care. Guidelines

  2025cites this paper
• The association between iron deficiency and muscle mass/strength in patients undergoing maintenance hemodialysis

  2025cites this paper
• Iron deficiency in chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty.

  2025cites this paper
• Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher‐ versus lower‐dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial

  2025cites this paper
• Association of elevated levels of soluble transferrin receptor with left ventricular remodeling and mortality in patients with heart failure: Evidence from observational and genetic investigations.

  2025cites this paper
• Rationale and design of the FAIR‐HF2‐DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure

  2025cites this paper
• Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program.

  2025cites this paper
• Cardiac Cachexia: A Comprehensive Review.

  2025cites this paper
• Metabolism-related gene PDK1 regulates myocardial cell remodeling and its mechanism

  2025cites this paper
• Cellular and Molecular Mechanisms Explaining the Link Between Inflammatory Bowel Disease and Heart Failure

  2025cites this paper
• Non cardiovascular comorbidities in Heart Failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC).

  2025cites this paper
• Iron Deficiency in Heart Failure: Cellular Mechanisms and Therapeutic Implications

  2025cites this paper
• Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study

  2025cites this paper
• Myocardial Performance Improvement After Iron Replacement in Heart Failure Patients: The IRON-PATH II Echo-Substudy

  2025cites this paper
• Effect of intravenous iron therapy on exercise performance, fatigue scores and mood states in iron-deficient recreationally active females of reproductive age: a double-blind, randomised control trial (IRONWOMAN Trial)

  2025cites this paper
• Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

  2025cites this paper
• The regulatory effect of blood group on ferritin levels in aging: a retrospective study

  2025cites this paper
• Diagnosis and treatment of iron deficiency in chronic heart failure

  2025cites this paper
• Iron Status in Sport Horses: Is It Important for Equine Athletes?

  2025cites this paper
• Metabolic Disturbances Involved in Cardiovascular Diseases: The Role of Mitochondrial Dysfunction, Altered Bioenergetics and Oxidative Stress

  2025cites this paper
• Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge

  2025cites this paper
• Anemia in cardiorenal disease: From pathogenesis to treatment.

  2025cites this paper
• Expanding the Concept of Iron Deficiency Using a Mitochondrial Metabolic Approach: Explaining and Preventing Sudden Death

  2025cites this paper
• Nutrient-Induced Remodeling of the Adipose-Cardiac Axis: Metabolic Flexibility, Adipokine Signaling, and Therapeutic Implications for Cardiometabolic Disease

  2025cites this paper
• Iron deficiency in the elderly. Evidences from different clinical settings and efficacy of iron supplementation on outcomes

  2025cites this paper
• Iron Deficiency Promotes Intra-leaflet Haemorrhage-induced Aortic Valve Calcification: an Experimental Study.

  2024cites this paper
• The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

  2024cites this paper
• Iron Deficiency in Collegiate Athletes Obtaining Preparticipation Hemoglobinopathy Screening in the Upper Midwest

  2024cites this paper
• Perinatal iron deficiency alters the cardiac proteome and mitochondrial function in neonatal offspring.

  2024cites this paper
• Ferric carboxymaltose reduces the burden of arrhythmic events in heart failure with reduced ejection fraction: the role of the non-invasive arrhythmic biomarkers.

  2024cites this paper
• Clinical Update in Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• The impact of iron deficiency on patients under evaluation for colorectal cancer, a prospective cross-sectional study

  2024cites this paper
• A two-pronged approach to inhibit ferroptosis of MSCs caused by the iron overload in postmenopausal osteoporosis and promote osseointegration of titanium implant

  2024cites this paper
• Proteomic Investigation of Neurotrophic trans-Banglene Reveals Potential Link to Iron Homeostasis

  2024cites this paper
• Redefining Iron Deficiency in Patients With Chronic Heart Failure

  2024cites this paper
• Exploring the association between haematological markers of iron and general movements in 4-month-old infants exposed to anaemia in-utero.

  2024cites this paper
• Iron and cardiovascular health: A review

  2024cites this paper
• Association of Iron Therapy with Mortality in Patients with Acute Myocardial Infarction and Iron Deficiency

  2024cites this paper
• Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure

  2024cites this paper
• Cathodoluminescent and Characteristic X‐Ray‐Emissive Rare‐Earth‐Doped Core/Shell Protein Labels for Spectromicroscopic Analysis of Cell Surface Receptors

  2024cites this paper
• Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

  2024cites this paper
• The Global Prevalence of Iron Deficiency in Collegiate Athletes: A Systematic Review and Meta‐Analysis

  2024cites this paper
• Interaction between systemic iron parameters and left ventricular structure and function in the preserved ejection fraction population: a two-sample bidirectional Mendelian randomization study.

  2024cites this paper
• Effectiveness of antianemic therapy for patients with severe iron deficiency anemia

  2024cites this paper
• DMT1 Maintains Iron Homeostasis to Regulate Mitochondrial Function in Porcine Oocytes

  2024cites this paper
• Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches

  2024cites this paper
• Impact of transferrin saturation on cardiovascular events in non-dialysis-dependent chronic kidney disease patients treated with darbepoetin alfa

  2024cites this paper
• Identification of three mechanistic pathways for iron-deficient heart failure

  2024influential citation
• The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy.

  2024cites this paper
• Effects of SGLT2 Inhibitors with and without Metformin in High-Risk, Treatment-Naïve Patients with Diabetes

  2024cites this paper
• Driving factors of neuronal ferroptosis.

  2024cites this paper
• Iron deficiency in patients with a Fontan circulation and its impact on exercise capacity

  2024cites this paper
• Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review.

  2024cites this paper
• Defining Iron Deficiency in Heart Failure: Importance of Transferrin Saturation.

  2024cites this paper
• Failure to thrive in pediatric patients with congenital heart disease: a cross-sectional study of 13,256 patients

  2024cites this paper
• Iron Deficiency and Incident Heart Failure in Older Community‐Dwelling Individuals

  2024cites this paper
• Elevated SLC40A1 impairs cardiac function and exacerbates mitochondrial dysfunction, oxidative stress, and apoptosis in ischemic myocardia

  2024cites this paper
• Iron biology.

  2024cites this paper
• LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2

  2024cites this paper
• Inflammation, dysregulated iron metabolism, and cardiovascular disease

  2023cites this paper
• SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism

  2023cites this paper
• Computational evaluation of heart failure and continuous flow left ventricular assist device support in anaemia

  2023influential citation
• Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.

  2023cites this paper
• IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes

  2023cites this paper
• Iron Deficiency in Chronic Pediatric Heart Failure: Overall Assessment and Outcomes in Dilated Cardiomyopathy.

  2023cites this paper
• Cardiac Iron Metabolism During Aging - Role of Inflammation and Proteolysis.

  2023cites this paper
• The treatment of chronic anemia in heart failure: a global approach

  2023cites this paper
• Iron deficiency in myocardial ischemia: molecular mechanisms and therapeutic perspectives.

  2023cites this paper
• Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction.

  2023cites this paper
• Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx)

  2023cites this paper
• Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study

  2023cites this paper
• Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

  2023cites this paper
• [Iron deficiency in cardiac surgery patients and the possibility of its correction at the preoperative stage].

  2023cites this paper
• The Role of Metabolic Syndrome in The Nature of Postinfarction Remodeling of The Heart in Patients with Chronic Heart Failure

  2023cites this paper
• Iron Deficiency Might Impair the Recovery of Left Ventricular Function after Surgical Revascularization in Diabetic Patients: A Retrospective Study

  2023cites this paper
• Ferric carboxymaltose for patients with heart failure in all-range ejection fraction

  2023cites this paper
• Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

  2023cites this paper
• Gut microbiota bridges the iron homeostasis and host health

  2023cites this paper
• A new mechanism of therapeutic effect of stachydrine on heart failure by inhibiting myocardial ferroptosis.

  2023cites this paper
• Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.

  2023cites this paper
• Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature

  2023cites this paper
• Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx)

  2023cites this paper
• Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation

  2023cites this paper
• Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study

  2023cites this paper